Detalhe da pesquisa
1.
Assessment of Temporary Warfarin Reversal in Patients With Left Ventricular Assist Devices: the KVAD Study.
J Card Fail
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521486
2.
Multicenter evaluation of left ventricular assist device implantation with or without ECMO bridge in cardiogenic shock.
Artif Organs
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459758
3.
Activated Clotting Times Demonstrate Weak Correlation With Heparin Dosing in Adult Extracorporeal Membrane Oxygenation.
Am J Ther
; 29(4): e385-e393, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833874
4.
Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia.
J Thromb Thrombolysis
; 54(4): 597-604, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129561
5.
Extended duration venous thromboembolism prophylaxis with betrixaban for patients re-admitted with venous thromboembolism.
J Thromb Thrombolysis
; 52(1): 22-29, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33835335
6.
Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management service.
J Thromb Thrombolysis
; 51(2): 405-412, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651889
7.
Cerebrovascular Accidents During Mechanical Circulatory Support: New Predictors of Ischemic and Hemorrhagic Strokes and Outcome.
Stroke
; 49(5): 1197-1203, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29643259
8.
Expanding anticoagulation management services to include direct oral anticoagulants.
J Thromb Thrombolysis
; 45(2): 274-280, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29274044
9.
Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices.
J Thromb Thrombolysis
; 46(2): 180-185, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785470
10.
Prospective evaluation of a bivalirudin to warfarin transition nomogram.
J Thromb Thrombolysis
; 43(4): 498-504, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28102475
11.
Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program.
J Thromb Thrombolysis
; 42(4): 616-22, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27501998
12.
Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experience.
J Thromb Thrombolysis
; 52(1): 158-160, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085044
13.
Comparison of Time to Therapeutic aPTT in Patients Who Received Continuous Unfractionated Heparin After Implementation of Pharmacy-wide Intervention Alerts.
Hosp Pharm
; 51(8): 656-661, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27698506
14.
Coordinating emergent procedures after andexanet alfa.
Am J Hematol
; 94(10): E278-E282, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31342554
15.
Andexanet alfa-The first 150 days.
Am J Hematol
; 94(1): E21-E24, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30358896
16.
Pharmacy Response to the Boston Marathon Bombings at a Tertiary Academic Medical Center.
Ann Pharmacother
; 48(8): 1082-1085, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24842858
17.
Impact of as needed heparin boluses on supratherapeutic activated partial thromboplastin time in patients managed with extracorporeal membrane oxygenation.
Crit Pathw Cardiol
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38285539
18.
One-year retrospective analysis of anti-FXa apixaban and rivaroxaban levels demonstrates utility for management decisions in various urgent and nonurgent clinical situations.
Am J Clin Pathol
; 160(6): 571-584, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549067
19.
Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time Periods.
Am J Med
; 136(9): 927-936.e3, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247752
20.
Idarucizumab for urgent reversal of dabigatran for heart transplant: A case report.
Am J Hematol
; 92(3): E34-E35, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28033655